chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Tested positive for Covid; This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for Covid) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for Covid). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, SARS-CoV-2 test: positive (Positive) positive test.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-030804 (Patient Link).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Headache; Headache , joint pain , muscle pain; Muscle pain; Chills; Fever; Tenderness to touch at left arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness to touch at left arm), FATIGUE (Fatigue), HEADACHE (Headache), ARTHRALGIA (Headache , joint pain , muscle pain) and MYALGIA (Muscle pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced TENDERNESS (Tenderness to touch at left arm), FATIGUE (Fatigue), ARTHRALGIA (Headache , joint pain , muscle pain), MYALGIA (Muscle pain), CHILLS (Chills) and PYREXIA (Fever). On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, TENDERNESS (Tenderness to touch at left arm), FATIGUE (Fatigue), HEADACHE (Headache), ARTHRALGIA (Headache , joint pain , muscle pain), MYALGIA (Muscle pain), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and treatment information were reported.   This case was linked to MOD-2021-031736 (Patient Link).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Headache; Headache , joint pain , muscle pain; Muscle pain; Chills; Fever; Tenderness to touch at left arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness to touch at left arm), FATIGUE (Fatigue), HEADACHE (Headache), ARTHRALGIA (Headache , joint pain , muscle pain) and MYALGIA (Muscle pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A214) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced TENDERNESS (Tenderness to touch at left arm), FATIGUE (Fatigue), ARTHRALGIA (Headache , joint pain , muscle pain), MYALGIA (Muscle pain), CHILLS (Chills) and PYREXIA (Fever). On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, TENDERNESS (Tenderness to touch at left arm), FATIGUE (Fatigue), HEADACHE (Headache), ARTHRALGIA (Headache , joint pain , muscle pain), MYALGIA (Muscle pain), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and treatment information were reported.   This case was linked to MOD-2021-031736 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fall, Gait disturbance, Product dose omission issue
Clinical narrative: doctors said for her not to takethe second dose because of her symptoms from the 1st dose of the Moderna vaccine.; dizziness; fell; had to use a walker; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (doctors said for her not to takethe second dose because of her symptoms from the 1st dose of the Moderna vaccine.), DIZZINESS (dizziness), FALL (fell) and GAIT DISTURBANCE (had to use a walker) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced DIZZINESS (dizziness), FALL (fell) and GAIT DISTURBANCE (had to use a walker). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (doctors said for her not to takethe second dose because of her symptoms from the 1st dose of the Moderna vaccine.). In February 2021, DIZZINESS (dizziness), FALL (fell) and GAIT DISTURBANCE (had to use a walker) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (doctors said for her not to takethe second dose because of her symptoms from the 1st dose of the Moderna vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information was provided.  No concomitant product information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Significant follow up appended to AER On 04-May-2021: no new information On 16-Jul-2021: No new information received.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Attention deficit hyperactivity disorder, Disturbance in attention, Fatigue, Visual impairment
Clinical narrative: visual problems/almost like double vision; couldn't focus; almost like i had ADD; felt very tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VISUAL IMPAIRMENT (visual problems/almost like double vision), DISTURBANCE IN ATTENTION (couldn't focus), ATTENTION DEFICIT HYPERACTIVITY DISORDER (almost like i had ADD) and FATIGUE (felt very tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included Postural orthostatic tachycardia syndrome since 2019. Concurrent medical conditions included Cataract and Allergy NOS.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced VISUAL IMPAIRMENT (visual problems/almost like double vision), DISTURBANCE IN ATTENTION (couldn't focus), ATTENTION DEFICIT HYPERACTIVITY DISORDER (almost like i had ADD) and FATIGUE (felt very tired).   At the time of the report, VISUAL IMPAIRMENT (visual problems/almost like double vision) had not resolved and DISTURBANCE IN ATTENTION (couldn't focus), ATTENTION DEFICIT HYPERACTIVITY DISORDER (almost like i had ADD) and FATIGUE (felt very tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Hypoaesthesia, Pain
Clinical narrative: Tingling in her lips and mouth; numbness; headaches; Chills; achy; Feeling miserable; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling miserable), PARAESTHESIA ORAL (Tingling in her lips and mouth), PAIN (achy), HYPOAESTHESIA (numbness) and HEADACHE (headaches) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014MZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FEELING ABNORMAL (Feeling miserable) and CHILLS (Chills). 26-Feb-2021, the patient experienced PAIN (achy) and HEADACHE (headaches). On 01-Mar-2021, the patient experienced PARAESTHESIA ORAL (Tingling in her lips and mouth) and HYPOAESTHESIA (numbness). On 27-Feb-2021, PAIN (achy), HEADACHE (headaches) and CHILLS (Chills) had resolved. On 28-Feb-2021, FEELING ABNORMAL (Feeling miserable) had resolved. On 03-Mar-2021, PARAESTHESIA ORAL (Tingling in her lips and mouth) and HYPOAESTHESIA (numbness) had resolved.            No concomitant medications were provided by the reporter.   Treatment information was not provided.  The action taken with mRNA with the events was considered as not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up information received on 15-JULY-2021 and contains significant information. Email address added. New events and outcome added.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: Tingling in her lips and mouth; numbness; headaches; Chills; achy; Feeling miserable; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling miserable), PARAESTHESIA ORAL (Tingling in her lips and mouth), PAIN (achy), HYPOAESTHESIA (numbness) and HEADACHE (headaches) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014MZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FEELING ABNORMAL (Feeling miserable) and CHILLS (Chills). 26-Feb-2021, the patient experienced PAIN (achy) and HEADACHE (headaches). On 01-Mar-2021, the patient experienced PARAESTHESIA ORAL (Tingling in her lips and mouth) and HYPOAESTHESIA (numbness). On 27-Feb-2021, PAIN (achy), HEADACHE (headaches) and CHILLS (Chills) had resolved. On 28-Feb-2021, FEELING ABNORMAL (Feeling miserable) had resolved. On 03-Mar-2021, PARAESTHESIA ORAL (Tingling in her lips and mouth) and HYPOAESTHESIA (numbness) had resolved.            No concomitant medications were provided by the reporter.   Treatment information was not provided.  The action taken with mRNA with the events was considered as not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up information received on 15-JULY-2021 and contains significant information. Email address added. New events and outcome added.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain in extremity
Clinical narrative: His arm is very sore; He has a little bit of muscular and joint discomfort (feels like tight, like sleeping too long and need to move); He has a little bit of muscular and joint discomfort (feels like tight, like sleeping too long and need to move); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (His arm is very sore), MYALGIA (He has a little bit of muscular and joint discomfort (feels like tight, like sleeping too long and need to move)) and ARTHRALGIA (He has a little bit of muscular and joint discomfort (feels like tight, like sleeping too long and need to move)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN IN EXTREMITY (His arm is very sore), MYALGIA (He has a little bit of muscular and joint discomfort (feels like tight, like sleeping too long and need to move)) and ARTHRALGIA (He has a little bit of muscular and joint discomfort (feels like tight, like sleeping too long and need to move)). At the time of the report, PAIN IN EXTREMITY (His arm is very sore), MYALGIA (He has a little bit of muscular and joint discomfort (feels like tight, like sleeping too long and need to move)) and ARTHRALGIA (He has a little bit of muscular and joint discomfort (feels like tight, like sleeping too long and need to move)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Body temperature, Chills, Fatigue
Clinical narrative: rash across top part of stomach with mild itching,rash across top part of hips with mild itching; sore stomach; body aches; fever (101.2°F); chills; fatigue; joint pain; This spontaneous case was reported by a health care professional and describes the occurrence of RASH PRURITIC (rash across top part of stomach with mild itching,rash across top part of hips with mild itching), ABDOMINAL PAIN UPPER (sore stomach), PAIN (body aches), PYREXIA (fever (101.2°F)) and CHILLS (chills) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no historical condition was reported).    On 21-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (rash across top part of stomach with mild itching,rash across top part of hips with mild itching), ABDOMINAL PAIN UPPER (sore stomach), PAIN (body aches), PYREXIA (fever (101.2°F)), CHILLS (chills), FATIGUE (fatigue) and ARTHRALGIA (joint pain). At the time of the report, RASH PRURITIC (rash across top part of stomach with mild itching,rash across top part of hips with mild itching), ABDOMINAL PAIN UPPER (sore stomach), PAIN (body aches), PYREXIA (fever (101.2°F)), CHILLS (chills), FATIGUE (fatigue) and ARTHRALGIA (joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.2 f.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitants or treatment medications were reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Rash pruritic
Clinical narrative: rash across top part of stomach with mild itching,rash across top part of hips with mild itching; sore stomach; body aches; fever (101.2°F); chills; fatigue; joint pain; This spontaneous case was reported by a health care professional and describes the occurrence of RASH PRURITIC (rash across top part of stomach with mild itching,rash across top part of hips with mild itching), ABDOMINAL PAIN UPPER (sore stomach), PAIN (body aches), PYREXIA (fever (101.2°F)) and CHILLS (chills) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no historical condition was reported).    On 21-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (rash across top part of stomach with mild itching,rash across top part of hips with mild itching), ABDOMINAL PAIN UPPER (sore stomach), PAIN (body aches), PYREXIA (fever (101.2°F)), CHILLS (chills), FATIGUE (fatigue) and ARTHRALGIA (joint pain). At the time of the report, RASH PRURITIC (rash across top part of stomach with mild itching,rash across top part of hips with mild itching), ABDOMINAL PAIN UPPER (sore stomach), PAIN (body aches), PYREXIA (fever (101.2°F)), CHILLS (chills), FATIGUE (fatigue) and ARTHRALGIA (joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.2 f.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitants or treatment medications were reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma
Clinical narrative: Asthma Attack; A spontaneous report () was received from a consumer for a 67 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced asthma attack.  The patient's medical history was not reported. No concomitant product use was reported.  On 24 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 25 Feb 2021, next day after receiving the vaccine, the patient experienced an asthma attack and used a rescue inhaler (albuterol) and the asthma responded. She then had a severe asthma attack same evening, went to emergency room about midnight and was treated with albuterol breathing treatment and given a cortisone shot.  Action taken with mRNA-1273 with respect to the event was not reported.  The outcome of the event was recovered on 26 Feb 2021.  The reporter did not provide the causality assessment for the event.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Had a lump; It swelled up; Red; Covid arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE NODULE (Had a lump), VACCINATION SITE SWELLING (It swelled up), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE PAIN (Covid arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced INJECTION SITE NODULE (Had a lump), VACCINATION SITE SWELLING (It swelled up), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE PAIN (Covid arm).   At the time of the report, INJECTION SITE NODULE (Had a lump), VACCINATION SITE SWELLING (It swelled up), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE PAIN (Covid arm) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash, Swelling
Clinical narrative: soreness in arm; Rash all over body; swollen bumps all over their body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm), RASH (Rash all over body) and SWELLING (swollen bumps all over their body) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported). Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced RASH (Rash all over body) and SWELLING (swollen bumps all over their body). On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in arm). At the time of the report, PAIN IN EXTREMITY (soreness in arm), RASH (Rash all over body) and SWELLING (swollen bumps all over their body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Hypersensitivity, Paraesthesia, Throat irritation
Clinical narrative: internal tickle in her chest that has been happening on and off since the initial symptom; Throat tickle; Allergies; Internal tickle in her chest that has been happening on and off since the initial symptom; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Internal tickle in her chest that has been happening on and off since the initial symptom), CHEST DISCOMFORT (internal tickle in her chest that has been happening on and off since the initial symptom), THROAT IRRITATION (Throat tickle) and HYPERSENSITIVITY (Allergies) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced PARAESTHESIA (Internal tickle in her chest that has been happening on and off since the initial symptom) and HYPERSENSITIVITY (Allergies). 28-Jan-2021, the patient experienced THROAT IRRITATION (Throat tickle). On 28-Jan-2021 at 6:30 PM, the patient experienced CHEST DISCOMFORT (internal tickle in her chest that has been happening on and off since the initial symptom). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (Internal tickle in her chest that has been happening on and off since the initial symptom), CHEST DISCOMFORT (internal tickle in her chest that has been happening on and off since the initial symptom), THROAT IRRITATION (Throat tickle) and HYPERSENSITIVITY (Allergies) had resolved.            The patient reported that since the event throat tickle began the day she had the second dose, it obviously was not related, it had to be allergies. She did not check with a doctor.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: The event, throat irritation was added. The treatment information was added. On 07-Jul-2021: Event outcome was updated and event was added. Corrections made to initial report: suspect product (first dose start date and lot number added) and concomitant medication added.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Hot rash; Red rash; rash on the arm where she received the vaccine.; Swollen rash; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE WARMTH (Hot rash), RASH ERYTHEMATOUS (Red rash), VACCINATION SITE RASH (rash on the arm where she received the vaccine.) and VACCINATION SITE SWELLING (Swollen rash) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT RAPIHALER) and CALCIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM CHLORIDE (FLO NASAL MIST) for Asthma, MONTELUKAST SODIUM (SINGULAIR), ROSUVASTATIN CALCIUM (CRESTOR), VITAMIN B12 [VITAMIN B12 NOS], VITAMIN D3 and L-LYSINE [LYSINE] for an unknown indication.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot rash), RASH ERYTHEMATOUS (Red rash), VACCINATION SITE RASH (rash on the arm where she received the vaccine.) and VACCINATION SITE SWELLING (Swollen rash). On 10-Feb-2021, VACCINATION SITE WARMTH (Hot rash), RASH ERYTHEMATOUS (Red rash), VACCINATION SITE RASH (rash on the arm where she received the vaccine.) and VACCINATION SITE SWELLING (Swollen rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details was not reported by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Myalgia, Nausea, Pain in extremity
Clinical narrative: flares,; arm pain.; body aches; nausea; This spontaneous case was reported by a physician and describes the occurrence of CONDITION AGGRAVATED (flares,), PAIN IN EXTREMITY (arm pain.), MYALGIA (body aches) and NAUSEA (nausea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced CONDITION AGGRAVATED (flares,), PAIN IN EXTREMITY (arm pain.), MYALGIA (body aches) and NAUSEA (nausea). At the time of the report, CONDITION AGGRAVATED (flares,), PAIN IN EXTREMITY (arm pain.), MYALGIA (body aches) and NAUSEA (nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were not reported by the reporter. Treatment included medication for nausea.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site irritation, Vaccination site pain, Vaccination site pruritus
Clinical narrative: the injection site is irritated; the injection site is itchy; the injection site is painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE IRRITATION (the injection site is irritated), VACCINATION SITE PRURITUS (the injection site is itchy) and VACCINATION SITE PAIN (the injection site is painful) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced VACCINATION SITE IRRITATION (the injection site is irritated), VACCINATION SITE PRURITUS (the injection site is itchy) and VACCINATION SITE PAIN (the injection site is painful). At the time of the report, VACCINATION SITE IRRITATION (the injection site is irritated), VACCINATION SITE PRURITUS (the injection site is itchy) and VACCINATION SITE PAIN (the injection site is painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported . Treatment details was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Significant follow up received included reporter address, patient date of birth, suspect route of administration and event onset date.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at the injection site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at the injection site). At the time of the report, VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  No treatment medications provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Hypogeusia
Clinical narrative: taste diminished; This spontaneous case was reported by a consumer and describes the occurrence of HYPOGEUSIA (taste diminished) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     Concomitant products included LOSARTAN POTASSIUM, AMLODIPINE, ATORVASTATIN, TIMOLOL and LATANOPROST for an unknown indication.  On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 01-Mar-2021, the patient experienced HYPOGEUSIA (taste diminished).   At the time of the report, HYPOGEUSIA (taste diminished) outcome was unknown.      Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Pain in extremity, Pyrexia
Clinical narrative: not feeling that great.; arm more sore than the flu shot; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feeling that great.), PAIN IN EXTREMITY (arm more sore than the flu shot), PYREXIA (fever) and CHILLS (chills) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Thyroid disorder NOS. Concomitant products included LISINOPRIL for Hypertension.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced MALAISE (not feeling that great.), PAIN IN EXTREMITY (arm more sore than the flu shot), PYREXIA (fever) and CHILLS (chills). At the time of the report, MALAISE (not feeling that great.), PAIN IN EXTREMITY (arm more sore than the flu shot), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included were water pill and thyroid medication. Treatment details were not reported by the reporter.   This case was linked to MOD21-027949 (E2B Linked Report).; Sender's Comments:  MOD21-027949:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Insomnia, Malaise
Clinical narrative: Sore throat; no appetite; Having trouble sleeping; Feels like have pneumonia; Fatigue; Chills; Fever; A spontaneous report () was received from a consumer concerning a 61-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever, fatigue, chills, feels like have pneumonia/malaise, loss of appetite/appetite lost, having trouble sleeping/difficulty sleeping and sore throat.  The patient's medical history included high blood pressure and asthma. Concomitant medications reported were metformin, acetylsalicylic acid, enalapril, carbinoxamine maleate, cholecalciferol, women's multivitamin and an "asthma medication inhaler."  On 15-Feb-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 013M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 16-Feb-2021, the patient experienced extreme fatigue, chills, fever, and felt like had pneumonia. The patient had trouble sleeping, no appetite, sore throat. The patient stated that the fever had gotten better after taking Tylenol. She took Excedrin for symptoms.  Action taken with mRNA-1273 in response to the events was unknown.   The event, fever, was considered recovering/resolving, while the outcomes of the events of fatigue, chills, feels like have pneumonia, loss of appetite, having trouble sleeping, sore throat, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia
Clinical narrative: Sore throat; no appetite; Having trouble sleeping; Feels like have pneumonia; Fatigue; Chills; Fever; A spontaneous report () was received from a consumer concerning a 61-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fever, fatigue, chills, feels like have pneumonia/malaise, loss of appetite/appetite lost, having trouble sleeping/difficulty sleeping and sore throat.  The patient's medical history included high blood pressure and asthma. Concomitant medications reported were metformin, acetylsalicylic acid, enalapril, carbinoxamine maleate, cholecalciferol, women's multivitamin and an "asthma medication inhaler."  On 15-Feb-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 013M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 16-Feb-2021, the patient experienced extreme fatigue, chills, fever, and felt like had pneumonia. The patient had trouble sleeping, no appetite, sore throat. The patient stated that the fever had gotten better after taking Tylenol. She took Excedrin for symptoms.  Action taken with mRNA-1273 in response to the events was unknown.   The event, fever, was considered recovering/resolving, while the outcomes of the events of fatigue, chills, feels like have pneumonia, loss of appetite, having trouble sleeping, sore throat, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Vaccination site erythema, Vaccination site swelling
Clinical narrative: SWOLLEN ARM; REDNESS; PAINFUL; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (SWOLLEN ARM), VACCINATION SITE ERYTHEMA (REDNESS) and AXILLARY PAIN (PAINFUL) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On an unknown date, the patient experienced VACCINATION SITE SWELLING (SWOLLEN ARM), VACCINATION SITE ERYTHEMA (REDNESS) and AXILLARY PAIN (PAINFUL).   At the time of the report, VACCINATION SITE SWELLING (SWOLLEN ARM), VACCINATION SITE ERYTHEMA (REDNESS) and AXILLARY PAIN (PAINFUL) outcome was unknown.      Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rhinorrhoea
Clinical narrative: nose is running; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and RHINORRHOEA (nose is running) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 11-Feb-2021, the patient experienced RHINORRHOEA (nose is running). At the time of the report, PAIN IN EXTREMITY (sore arm) and RHINORRHOEA (nose is running) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included medication for diabetes. Treatment details included none.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pain in extremity, Pyrexia
Clinical narrative: Body ache; Sore arm; A lot of tiredness; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), PAIN IN EXTREMITY (Sore arm), FATIGUE (A lot of tiredness), PYREXIA (Fever) and CHILLS (Chills) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No concomitant medication details were not reported by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (Body ache), PAIN IN EXTREMITY (Sore arm), FATIGUE (A lot of tiredness), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PAIN (Body ache), PAIN IN EXTREMITY (Sore arm), FATIGUE (A lot of tiredness), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details were not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Lymphoedema, Swelling
Clinical narrative: lymphedema - in my opposite arm - left arm; sweats; chills; headache; swelling; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHOEDEMA (lymphedema - in my opposite arm - left arm), HYPERHIDROSIS (sweats), CHILLS (chills), HEADACHE (headache) and SWELLING (swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHOEDEMA (lymphedema - in my opposite arm - left arm), HYPERHIDROSIS (sweats), CHILLS (chills), HEADACHE (headache) and SWELLING (swelling). At the time of the report, LYMPHOEDEMA (lymphedema - in my opposite arm - left arm), HYPERHIDROSIS (sweats), CHILLS (chills), HEADACHE (headache) and SWELLING (swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-058199 (Patient Link).   Reporter did not allow further contact
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration
Clinical narrative: Hard to the touch; Redness at the injection site /Redness 7 inches long/Redness 5 inches wide; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Hard to the touch) and VACCINATION SITE ERYTHEMA (Redness at the injection site /Redness 7 inches long/Redness 5 inches wide) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026120A) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and FOLIC ACID for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE INDURATION (Hard to the touch) and VACCINATION SITE ERYTHEMA (Redness at the injection site /Redness 7 inches long/Redness 5 inches wide). At the time of the report, VACCINATION SITE INDURATION (Hard to the touch) and VACCINATION SITE ERYTHEMA (Redness at the injection site /Redness 7 inches long/Redness 5 inches wide) had resolved.            No treatment information was provided.   Patient's concomitant drugs included medications for Depression, Blood pressure, Gastric reflux meds and Inhaler.  Patient had a second dose event redness at the site which had recovered after a week.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15-JUL-2021. The second dose details were added and event outcome was changed to recovered.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Nausea
Clinical narrative: High Blood Pressure; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High Blood Pressure) and NAUSEA (Nausea) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant medication details were not reported by the reporter.  Concomitant products included APIXABAN (ELIQUIS), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN CALCIUM (LIPITOR), DOCOSAHEXAENOIC ACID (OMEGA 3 DHA [DOCOSAHEXAENOIC ACID]), DENOSUMAB (PROLIA), DEXTROMETHORPHAN HYDROBROMIDE (DELSYM), DILTIAZEM, LEVOTHYROXINE, LISINOPRIL, TRIAMCINOLONE ACETONIDE (KENALOG [TRIAMCINOLONE ACETONIDE]) and ASCORBIC ACID, RETINOL, TOCOPHEROL (OCUVITE [ASCORBIC ACID;RETINOL;TOCOPHEROL]) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced HYPERTENSION (High Blood Pressure) and NAUSEA (Nausea). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HYPERTENSION (High Blood Pressure) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration
Clinical narrative: Hardness; Big red spot about 1 inch below the deltoid muscle; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Big red spot about 1 inch below the deltoid muscle) and INDURATION (Hardness) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced ERYTHEMA (Big red spot about 1 inch below the deltoid muscle). On 17-Feb-2021, the patient experienced INDURATION (Hardness). At the time of the report, ERYTHEMA (Big red spot about 1 inch below the deltoid muscle) and INDURATION (Hardness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Very Severe Side Effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Very Severe Side Effects) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION COMPLICATION (Very Severe Side Effects). At the time of the report, VACCINATION COMPLICATION (Very Severe Side Effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Hyperhidrosis, Neck pain
Clinical narrative: excessive sweating; weakness; Neck ache; severe headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (excessive sweating), ASTHENIA (weakness), NECK PAIN (Neck ache), HEADACHE (severe headache) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced HYPERHIDROSIS (excessive sweating), ASTHENIA (weakness), NECK PAIN (Neck ache), HEADACHE (severe headache) and FATIGUE (fatigue). At the time of the report, HYPERHIDROSIS (excessive sweating), ASTHENIA (weakness), NECK PAIN (Neck ache), HEADACHE (severe headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling
Clinical narrative: Injection site swelling; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Injection site swelling) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced INJECTION SITE SWELLING (Injection site swelling). At the time of the report, INJECTION SITE SWELLING (Injection site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dry mouth, Paraesthesia, Tremor
Clinical narrative: hands were shaking really bad; felt tingling in arm and back; mouth was dry; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (hands were shaking really bad), PARAESTHESIA (felt tingling in arm and back), DRY MOUTH (mouth was dry) and DIZZINESS (dizziness) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced TREMOR (hands were shaking really bad), PARAESTHESIA (felt tingling in arm and back), DRY MOUTH (mouth was dry) and DIZZINESS (dizziness). On 16-Jan-2021, TREMOR (hands were shaking really bad), PARAESTHESIA (felt tingling in arm and back), DRY MOUTH (mouth was dry) and DIZZINESS (dizziness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       .